Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Topical Drug Delivery Market?

In the past few years, there has been a significant increase in the size of the topical drug delivery market. It is projected that it will boost from $163.87 billion in 2024 to $179.16 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. The expansion during the historical phase is credited to factors such as prevalent skin diseases, an aging demographic, a consumer inclination towards non-invasive therapies, common skin infections and a rise in consumer consciousness and self-care.

What Growth Rate Is Forecasted for the Topical Drug Delivery Market by 2029?

It is anticipated that the size of the topical drug delivery market will experience swift expansion in the near future. An estimated value of $280.58 billion is projected for this market by 2029, growing at a compound annual growth rate (CAGR) of 11.9%. Factors contributing to growth during the forecast period include the advent of transdermal patches, novel formulation methods, adoption of personalized medicine, advancements in telemedicine and remote consultations, and an increasing prevalence of chronic illnesses. The forecast period is also expected to witness trends such as the development of advanced formulations, personalized skincare, the introduction of 5g-enabled devices, improved compliance solutions, and the integration of sensors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7564&type=smp

Which Key Companies Are Shaping the Future of the Topical Drug Delivery Market?

Major companies operating in the topical drug delivery market include Glenmark Pharmaceuticals Ltd., Galderma SA, Johnson & Johnson Private Limited, GlaxoSmithKline PLC., Bausch Health Companies Inc., Novartis AG, Merck & Co., Hisamitsu Pharmaceuticals, Bayer AG, Cipla Limited, Viatris Inc., 3M Company, Crescita Therpeautics Inc., Boehringer Ingelheim International GmBH, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Bristol Myers Squibb, Lavipharm SA, AbbVie Inc., CMP Pharma Inc., Encore Dermatology Inc., Rusan Pharma Ltd., LEO Pharma A/S, Almirall S.A., Sun Pharmaceutical Industries Ltd., Fougera Pharmaceuticals Inc., Perrigo Company plc, Taro Pharmaceutical Industries Ltd., MedPharm Ltd.

Which Factors Are Driving Demand in the Topical Drug Delivery Industry?

The escalating incidence of diabetes is anticipated to drive the growth of the topical drug delivery market in the future. Diabetes comprises a multitude of diseases, impacting how the body processes blood sugar and often leading to elevated blood sugar levels. Topical drug delivery is beneficial for diabetes patients as it administers medicines that can circumvent hepatic first-pass metabolism. For instance, the IDF Diabetes Atlas, a Belgium-based international resource offering extensive data and insights on diabetes occurrence, treatment, and care globally, published in March 2022 estimates that the worldwide incidence of diabetes will rise from 643 million in 2030 to 783 million by 2045, resulting in an additional 140 million cases. At present, 537 million adults have diabetes, with over 75% residing in low- to middle-income nations.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7564&type=smp

How Is the Topical Drug Delivery Market Segmented by Several Divisions?

The topical drug delivery market covered in this report is segmented –

1) By Product Type: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products

2) By Route Of Administration: Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery

3) By End User: Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Other End Users

Subsegments:

1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes

2) By Liquid Formulations: Solutions, Suspensions, Emulsions, Lotions

3) By Solid Formulations: Powders, Granules, Solid Sticks

4) By Transdermal Products: Transdermal Patches, Microneedle Systems, Transdermal Gels

What are the Emerging Market Trends Driving the Growth of the Topical Drug Delivery Industry?

The rise in technological innovations is a prevailing trend in the topical drug delivery market. To consolidate their standing in the worldwide topical drug delivery market, major players are creating cutting-edge products employing advanced technology. An example of this occurred in April 2022 when Sol-Gel Technologies Ltd., a dermatology firm from Israel, collaborated with Galderma S.A., a Switzerland-based pharmaceutical company with speciality in dermatological treatments and skin care products. They launched Epsolay (benzoyl peroxide, cream, 5%), leveraging Sol-Gel’s patented microencapsulation technology, which will be protected until 2040, designed to treat inflammatory lesions of rosacea. The benefit of Sol-gel microencapsulation lies in the method it traps molecules and forms inclusion complexes with essential oils (Eos) playing the guest role and beta-cyclodextrin as the host within porous silica, improving stability and resistance to environmental conditions. Silica serves as a shield for EOs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/topical-drug-delivery-global-market-report

Which Regions Are Driving Growth in the Topical Drug Delivery Market?

North America was the largest region in the topical drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical drug delivery market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7564

This Report Delivers Insight On:

1. How big is the topical drug delivery market, and how is it changing globally?

2. Who are the major companies in the topical drug delivery market, and how are they performing?

3. What are the key opportunities and risks in the topical drug delivery market right now?

4. Which products or customer segments are growing the most in the topical drug delivery market?

5. What factors are helping or slowing down the growth of the topical drug delivery market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model